https://www.high-endrolex.com/17
產品櫥窗-塞魯士生技有限公司-最高品質,價格平實。您最好的研究夥伴。

塞魯士有限公司

免付費服務專線:080-007-2222

產品櫥窗

  • SP600125
  • 產品型號:101-129-56-6

    商品規格:

    商品售價

Selective inhibitor of c-Jun N-terminal kinase (JNK)

Synonyms: Anthra(1,9-cd)pyrazol-6(2H)-one, 1,9-Pyrazoloanthrone, Anthrapyrazolone, JNK Inhibitor II, SAPK Inhibitor II, NSC 75890, 1PMV

>99%
C14H8N2O
M.W. 220.23

SP600125 is an anthrapyrazolone inhibitor of JNK that competes with ATP to inhibit the phosphorylation of c-Jun. It prevents the activation of inflammatory genes such as COX-2, IL-2 IFN-γ and TNF-α. It prevents the activation of JNK after brain ischemia and may be effective in treatment of ischemic stroke.

Solubility: Prepare initial stock solutions in DMSO (soluble at 65 mg/mL) for in vitro use; solubility in ethanol or water is low.

SP600125 inhibited JNK, reduced the levels of c-Jun phosphorylation, prevented apoptosis in dopaminergic neurons, and partly reversed the loss of dopamine in MPTP-induced Parkinson's disease in C57BL/6N mice. Wang W., et al. "SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease." Neurosci. Res. 48: 195-202 (2004).
Store at -20 ºC